I now have comprehensive data from authoritative textbooks. Let me compile the full detailed answer.
AKI vs CKD: Detailed Differentiation + AKI-on-CKD
Definitions First
| Feature | AKI | CKD |
|---|
| Definition | Abrupt rise in serum creatinine ≥0.3 mg/dL within 48 h, OR ≥1.5× baseline within 7 days, OR urine output <0.5 mL/kg/h for ≥6 h (KDIGO criteria) | eGFR <60 mL/min/1.73 m² persisting for >3 months, OR kidney damage markers persisting >3 months (proteinuria, hematuria, structural abnormality) |
| Time course | Hours to days | Months to years (by definition >3 months) |
| Reversibility | Potentially reversible with treatment | Usually irreversible; progressive |
1. History and Clinical Clues
Pointing to AKI
- Acute precipitating event: recent surgery, sepsis, hypotension, trauma, rhabdomyolysis, nephrotoxin exposure (NSAIDs, aminoglycosides, IV contrast, ACE inhibitors/ARBs, chemotherapy, herbal medicines)
- Sudden change in urine output (oliguria <500 mL/day or anuria)
- Recent hospitalization, burns, diarrhea, vomiting, bleeding
- Previously documented normal creatinine
Pointing to CKD
- Long-standing hypertension, diabetes mellitus, recurrent urinary tract infections, obstructive uropathy
- Family history of kidney disease (polycystic kidney disease)
- Prior abnormal creatinine or proteinuria on old records
- Symptoms of uraemia that have been building for months: fatigue, anorexia, nausea, pruritus, restless leg syndrome, peripheral neuropathy
"Knowledge of prior serum creatinine concentrations is required to determine the degree of potentially reversible AKI." - Comprehensive Clinical Nephrology, 7th Edition, p. 985
2. Urinary Output Pattern
| Pattern | Significance |
|---|
| Oliguria <500 mL/day | Common in AKI (especially ATN); also possible in severe CKD |
| Sudden anuria | Bilateral obstruction, bilateral renal artery occlusion - strongly AKI |
| Polyuria (large urine volumes despite rising creatinine) | Suggests CKD with tubular dysfunction; or recovering AKI |
| Nonoliguric AKI | AIN, contrast nephropathy, aminoglycosides |
3. Physical Examination
Favoring AKI
- Signs of acute volume depletion: low BP, tachycardia, dry mucous membranes, reduced JVP, weight loss
- Signs of acute cause: sepsis, bleeding, rhabdomyolysis bruising, toxin exposure
Favoring CKD
- Pallor (anaemia of chronic disease)
- Sallow/yellowish skin (uraemic pigmentation)
- Peripheral neuropathy (stocking-glove distribution)
- Uraemic frost (very late, rare)
- Hypertensive retinopathy, arteriovenous nicking on fundoscopy
- Cardiomegaly from long-standing hypertension
4. Laboratory Investigations - The Key Differentiators
A. Serum Creatinine & BUN Trajectory
| AKI | CKD |
|---|
| Rise in creatinine | Abrupt (hours-days) | Gradual (months-years) |
| Previous creatinine records | Normal | Chronically elevated |
| BUN/Creatinine ratio | >20:1 in prerenal AKI | 10:1 to 15:1 in CKD (unless uremia is superimposed) |
B. Urinary Indices (distinguish prerenal AKI from intrinsic AKI)
From Comprehensive Clinical Nephrology, 7th Edition (Table 72.3):
| Parameter | Prerenal AKI | Intrinsic AKI (e.g., ATN) |
|---|
| FENa | <1% | >1% |
| FEUrea | <35% | >35% |
| Urine Na (UNa) | <20 mmol/L | >40 mmol/L |
| Urine osmolality | >500 mOsm/kg | <350 mOsm/kg |
| Urine sediment | Normal/few hyaline casts | Muddy brown granular casts |
| BUN/SCr | >20 | <20 |
Important caveat: FENa has limited utility when AKI is superimposed on CKD - interpret cautiously. Contrast nephropathy and rhabdomyolysis can also give a falsely low FENa (<1%) due to early vasoconstriction. - Comprehensive Clinical Nephrology, 7th Edition
C. Haematology
| Parameter | AKI | CKD |
|---|
| Anaemia | Usually absent (or acute from bleeding) | Normocytic normochromic anaemia (EPO deficiency) - hallmark of CKD |
| Platelet count | May be low in TMA-associated AKI | Normal to mildly reduced |
| Peripheral smear | Schistocytes if TMA | Usually normal |
"Normocytic anemia, hyperparathyroidism, peripheral neuropathy, and broad waxy casts in the urinary sediment suggest CKD." - Comprehensive Clinical Nephrology, 7th Edition, p. 985
D. Calcium-Phosphate-PTH Axis
| AKI | CKD |
|---|
| Serum calcium | Low (in severe AKI) | Low |
| Serum phosphate | Elevated in severe AKI | Elevated (often >5 mg/dL) |
| PTH | Not elevated (or mildly elevated) | Elevated - secondary hyperparathyroidism (hallmark) |
| ALP/bone disease | Absent | Present (renal osteodystrophy) |
E. Urinalysis and Urine Sediment
| Finding | Suggests |
|---|
| Muddy brown granular casts | ATN (AKI) |
| Red cell casts | Glomerulonephritis (AKI cause) |
| White cell casts | Acute interstitial nephritis (AKI) |
| Broad waxy casts | CKD (form in dilated, widened tubules) |
| Hyaline casts | Prerenal AKI (benign, non-specific) |
| Proteinuria >1 g/day | Glomerular disease (can be AKI or CKD cause) |
| Eosinophiluria | AIN (AKI) |
5. Imaging - Ultrasound (Most Important Single Test)
Ultrasound is the first-line imaging for both AKI and CKD evaluation.
| Finding | Interpretation |
|---|
| Small kidneys (<9 cm), cortical thinning, increased echogenicity | CKD (irreversible scarring) |
| Normal or enlarged kidneys, normal echogenicity, hypoechoic medulla | AKI (interstitial edema, e.g., ATN) |
| Dilated pelvicalyceal system | Postrenal AKI (obstruction) |
| Large kidneys despite elevated creatinine | Can be CKD from diabetic nephropathy, amyloidosis, HIV nephropathy, ADPKD |
From National Kidney Foundation Primer on Kidney Diseases, 8th Edition:
"Small kidney size strongly supports a diagnosis of CKD, helping to differentiate acute from chronic kidney injury. Cortical echogenicity can be assessed, with a hyperechoic cortex present in most causes of CKD. In ATN, ultrasound usually shows enlarged kidneys with normal cortical echogenicity and a normal or hypoechoic medulla, primarily due to interstitial edema."
Renal resistive index (RI) on Doppler ultrasound: Normal ≤0.70. Elevated RI correlates with severity of AKI and predicts non-recovery. Emerging tool, operator-dependent.
6. Investigation and Management Flowchart
This is the standard diagnostic approach when elevated creatinine is found:
Fig. 72.2 - Comprehensive Clinical Nephrology, 7th Edition, p. 985
Key steps:
- Check baseline creatinine - if chronically elevated → CKD algorithm
- If creatinine >1.5× baseline or rises ≥0.3 mg/dL in 48 h → AKI confirmed
- Renal ultrasound to exclude obstruction
- History + physical + urine sediment to identify AKI cause
- If prerenal suspected → IV fluid challenge
- If intrinsic cause suspected → classify (ATN, AIN, GN, vascular)
- Biopsy if cause remains unclear after 2-3 weeks
7. Kidney Biopsy
Indicated in AKI when:
- Cause is not obvious
- Prolonged course >2-3 weeks without recovery
- AKI accompanied by heavy proteinuria and/or persistent hematuria
- Suspected GN, vasculitis, or systemic disease
- Biopsy needed to guide specific therapy (immunosuppression)
Biopsy in CKD: More dangerous when kidneys are small; findings often show non-specific end-stage changes (interstitial fibrosis, tubular atrophy).
8. Novel Biomarkers
These help identify AKI earlier than creatinine (which rises late):
| Biomarker | Role |
|---|
| NGAL (neutrophil gelatinase-associated lipocalin) | Rises within 2 hours of kidney injury; serum or urine |
| KIM-1 (kidney injury molecule-1) | Urine tubular injury marker |
| Cystatin C | More sensitive than creatinine for GFR estimation |
| IGFBP7 × TIMP-2 | Cell cycle arrest markers; predict AKI 12 hours before creatinine rise |
9. AKI on CKD (the third entity)
This is arguably the most clinically challenging scenario.
Definition
AKI superimposed on pre-existing CKD. The patient has a chronically impaired kidney that sustains an acute insult.
Why it matters
- CKD is one of the strongest risk factors for developing AKI
- Recovery is worse - the "creatinine return to baseline" standard breaks down when baseline itself is already reduced
- Risk of non-recovery and progression to end-stage kidney disease (ESKD) is substantially higher
Clues to AKI on CKD
- Known prior CKD (eGFR <60 for >3 months) with acute additional rise in creatinine
- Small kidneys on ultrasound (confirming CKD) + acute precipitant (confirming AKI component)
- Both anaemia of CKD (normocytic) AND muddy brown casts (ATN)
- Both elevated PTH AND evidence of an acute nephrotoxin/haemodynamic insult
- FENa has reduced utility in this setting - interpret with caution
- Background proteinuria from CKD + new oliguria from AKI
Risk Factors for CKD After AKI (Box 73.2, Comprehensive Clinical Nephrology 7th Ed.)
- Age
- Low baseline eGFR
- Congestive heart failure
- Hypertension
- Recurrent AKI episodes
- Low serum albumin during hospitalisation
- Severity of AKI (stage 3, need for dialysis)
- Low eGFR at hospital discharge
10. Summary Comparison Table
| Feature | AKI | CKD | AKI on CKD |
|---|
| Onset | Hours to days | Months to years | Acute rise on chronic baseline |
| Prior creatinine | Normal | Chronically elevated | Chronically elevated with new jump |
| Kidney size | Normal/enlarged | Small, echogenic | Small (CKD) + edematous |
| Anaemia | Absent or acute | Normocytic (EPO deficiency) | Normocytic + may worsen acutely |
| PTH | Normal | Elevated | Elevated |
| Urine casts | Muddy brown, RBC, WBC casts | Broad waxy casts | Mixed |
| FENa | <1% (prerenal), >1% (ATN) | Not typically used | Limited utility |
| Reversibility | Potentially fully reversible | Not reversible | Partial recovery; high ESKD risk |
| Ultrasound | Normal/enlarged kidneys | Small, scarred kidneys | Small kidneys + may show obstruction |
| PTH/bone disease | Absent | Present | Present |
| Biopsy | If cause unclear | If diagnosis unclear | Higher risk; may show combined picture |
Sources:
- Comprehensive Clinical Nephrology, 7th Edition, Chapter 72 - AKI Diagnosis and Chapter 73 - AKI Outcomes, pp. 985-999
- National Kidney Foundation Primer on Kidney Diseases, 8th Edition, Chapter on Imaging in AKI
- Brenner and Rector's The Kidney, 2-Volume Set - AKI Markers and AKI-CKD Transition
- Recent reviews: AKI-to-CKD transition mechanisms (PMID: 39298548, Am J Physiol Renal Physiol 2024) and AKI-CKD transition update (PMID: 38653563, Yonsei Med J 2024)